Heptares Therapeutics' Series A - II Round

Heptares Therapeutics raised a round of funding on April 06, 2011. Investors include Takeda Ventures.

Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors (GPCRs). Heptares StaR (Stabilized Receptor) technology enables thermo-stabilization…

Articles about Heptares Therapeutics' Series A - II Round: